Search research articles
Contact Us
Filters
Showing results (211-220 of 249) with videos related to
Page
of 25
Sort By:
JHEP Reports : Innovation in Hepatology
|
May 27, 2024
Atezolizumab/bevacizumab or lenvatinib in hepatocellular carcinoma: Multicenter real-world study with focus on bleeding and thromboembolic events
Najib Ben Khaled, Marie Möller, Leonie S Jochheim, et al.
Nature Reviews. Gastroenterology & Hepatology
|
April 21, 2016
Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)
Jesus M Banales, Vincenzo Cardinale, Guido Carpino, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
November 13, 2019
GALAD Score Detects Early Hepatocellular Carcinoma in an International Cohort of Patients With Nonalcoholic Steatohepatitis
Jan Best, Lars P Bechmann, Jan-Peter Sowa, et al.
JHEP Reports : Innovation in Hepatology
|
April 30, 2026
Multicenter study of bleeding and thromboembolic events with durvalumab tremelimumab vs. atezolizumab and bevacizumab in advanced HCC
Najib Ben Khaled, Raphael Mohr, Leonie S Jochheim, et al.
The Lancet. Gastroenterology & Hepatology
|
December 14, 2024
Development, validation, and prognostic evaluation of LiverPRO for the prediction of significant liver fibrosis in primary care: a prospective cohort study
Katrine P Lindvig, Katrine H Thorhauge, Johanne K Hansen, et al.
European Journal of Clinical Investigation
|
May 15, 2025
Bridging the gap in obesity research: A consensus statement from the European Society for Clinical Investigation
Federico Carbone, Jean-Pierre Després, John P A Ioannidis, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
January 26, 2025
Precision in Liver Diagnosis: Varied Accuracy Across Subgroups and the Need for Variable Thresholds in Diagnosis of MASLD
Yasaman Vali, Anne-Marieke van Dijk, Jenny Lee, et al.
Journal of Hepatology
|
June 11, 2018
Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030
Chris Estes, Quentin M Anstee, Maria Teresa Arias-Loste, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
December 8, 2025
Expert Delphi Consensus on Surrogate Endpoints for Treatment Assessment in Metabolic Dysfunction-associated Steatohepatitis
Arun J Sanyal, Atsushi Nakajima, Elisabetta Bugianesi, et al.
Contemporary Clinical Trials
|
October 12, 2020
The European NAFLD Registry: A real-world longitudinal cohort study of nonalcoholic fatty liver disease
Timothy Hardy, Kristy Wonders, Ramy Younes, et al.
Page
of 25
Search research articles
Search
Showing results (211-220 of 249) with videos related to
Sort By:
Page
of 25
JHEP Reports : Innovation in Hepatology
|
May 27, 2024
Atezolizumab/bevacizumab or lenvatinib in hepatocellular carcinoma: Multicenter real-world study with focus on bleeding and thromboembolic events
Najib Ben Khaled, Marie Möller, Leonie S Jochheim, et al.
Nature Reviews. Gastroenterology & Hepatology
|
April 21, 2016
Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)
Jesus M Banales, Vincenzo Cardinale, Guido Carpino, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
November 13, 2019
GALAD Score Detects Early Hepatocellular Carcinoma in an International Cohort of Patients With Nonalcoholic Steatohepatitis
Jan Best, Lars P Bechmann, Jan-Peter Sowa, et al.
JHEP Reports : Innovation in Hepatology
|
April 30, 2026
Multicenter study of bleeding and thromboembolic events with durvalumab tremelimumab vs. atezolizumab and bevacizumab in advanced HCC
Najib Ben Khaled, Raphael Mohr, Leonie S Jochheim, et al.
The Lancet. Gastroenterology & Hepatology
|
December 14, 2024
Development, validation, and prognostic evaluation of LiverPRO for the prediction of significant liver fibrosis in primary care: a prospective cohort study
Katrine P Lindvig, Katrine H Thorhauge, Johanne K Hansen, et al.
European Journal of Clinical Investigation
|
May 15, 2025
Bridging the gap in obesity research: A consensus statement from the European Society for Clinical Investigation
Federico Carbone, Jean-Pierre Després, John P A Ioannidis, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
January 26, 2025
Precision in Liver Diagnosis: Varied Accuracy Across Subgroups and the Need for Variable Thresholds in Diagnosis of MASLD
Yasaman Vali, Anne-Marieke van Dijk, Jenny Lee, et al.
Journal of Hepatology
|
June 11, 2018
Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030
Chris Estes, Quentin M Anstee, Maria Teresa Arias-Loste, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
December 8, 2025
Expert Delphi Consensus on Surrogate Endpoints for Treatment Assessment in Metabolic Dysfunction-associated Steatohepatitis
Arun J Sanyal, Atsushi Nakajima, Elisabetta Bugianesi, et al.
Contemporary Clinical Trials
|
October 12, 2020
The European NAFLD Registry: A real-world longitudinal cohort study of nonalcoholic fatty liver disease
Timothy Hardy, Kristy Wonders, Ramy Younes, et al.
Page
of 25